US FDA OKs Maha lab’s liquid biopsy to detect cancer

A Nashik-based cancer laboratory on Friday announced that the US Food and Drug Administration (US FDA) has granted a “breakthrough device designation” for its liquid biopsy test to detect early-stage breast cancer.

Admin Admin
Nov 20, 2021 - 10:33
0 7
US FDA OKs Maha lab’s liquid biopsy to detect cancer
Linkup
A Nashik-based cancer laboratory on Friday announced that the US Food and Drug Administration (US FDA) has granted a “breakthrough device designation” for its liquid biopsy test to detect early-stage breast cancer.
Read More